ClinicalTrials.gg
RecruitingNCT05462301NORRNEUpdated Jul 16, 2024

Normal Reference Range for Neonatal Echocardiography

An observational study in Echocardiography, sponsored by Children's Hospital of Chongqing Medical University. Recruiting at 1 site in China. Open to participants aged 1 Day to 28 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-07-16.

Sponsored by Children's Hospital of Chongqing Medical University · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Nov 2022; still recruiting 3 years 11 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,500
Ages
1 Day to 28 Days
Sex
All
01

Study summary

Echocardiography is the main method of bedside examination of neonatal cardiac morphology, which can timely diagnose congenital heart disease and quantitatively assess its severity, but the diagnosis and evaluation process depends on the normal range of neonatal echocardiography.At present, there have been normal reference standards for echocardiography in children and adults at home and abroad, but there is no uniform standard for echocardiographic parameters in newborns, especially premature infants.This study intends to carry out a national multicenter, prospective, observational study to establish the reference range of echocardiography at different time periods after birth in newborns, and stratified according to gestational age, birth weight and gender, to conduct a more accurate hemodynamic assessment of clinically critically ill newborns and guide the treatment of critically ill newborns in real time.

Read the detailed description

Neonatal goal-directed echocardiography (TNE) performed by neonatologists has been increasingly applied to hemodynamic assessment in the NICU to guide critical neonatal treatment in real time. There are many detection indexes of TNE, which are closely related to neonatal weight, birth weight, postnatal age, race and other factors. Therefore, establishing neonatal echocardiographic reference ranges is essential for the development of TNE. At present, there have been normal reference standards for echocardiography in children and adults at home and abroad, but there is no uniform standard for echocardiographic parameters in newborns, especially premature infants. At present, there are many problems in establishing the reference range of neonatal echocardiography internationally, including the small sample size included in establishing the reference range, no premature infant standard for some parameters, the reference range is not stratified according to gender, etc. Moreover, the majority of current echocardiographic reference ranges are derived from studies in European and American populations and are not applicable to Asian patients. So far, reference ranges for neonatal echocardiography established based on high-quality clinical studies are still lacking, greatly affecting the use of echocardiography in neonatal intensive care units. Therefore, this study intends to carry out a national multicenter, prospective, observational study to establish the reference range of echocardiography at different time periods after birth in neonates, and stratify according to creatinine, birth weight and gender, providing a reference for the application of echocardiography in neonatal intensive care units, and providing an important basis for the development of TNE-centered neonatal hemodynamic comprehensive assessment program in the NICU.

  1. Study Design and Process:

    This study is a multicenter, prospective, observational study. Neonatal bedside echocardiography was performed by a trained neonatology clinician or sonographer. Five time points were selected for neonatal echocardiography, namely, 1 day, 3 days, 7 days, 14 days, and 28 days after birth. The examination was completed in the quiet state of the newborn, and the measurement method was based on the American Guidelines and Standards for Echocardiography in Children and the American NICU Echocardiography Practice Guidelines. All ultrasound data were averaged over three or more cardiac cycles.

  2. Sample Size Calculation:

    Each participating NICU will be required to enroll 300 infants (60 infants for each PNA timepoint) for a final sample size of 1500 "normal infants".

  3. Statistical Methods:

    Data statistics were performed using SPSS 21.0 software. The data obtained for each of the ultrasound hemodynamic parameters were tested for normality. The measurement data conforming to normal distribution are expressed by mean ± standard deviation, and the measurement data with non-normal distribution are expressed by median (interquartile range). Spearman correlation analysis was used to compare the correlation between different indicators and postnatal, birth weight, birth weight and gender. The echocardiographic reference range of newborns at different time periods after birth was established by 95% confidence interval and stratified according to birth weight, birth weight and gender. P \< 0.05 was considered statistically significant.

  4. Quality control:

At the beginning of the study, a cooperative group kick-off meeting will be organized to interpret the study protocol in detail. In addition, the online or offline training of the participating units will be carried out to further unify the parameter setting and data collection criteria of the ultrasound machine. Establish a WeChat group to answer questions related to this study at any time. During the process of the project, regular contact meetings within the cooperative group will be held to ensure that the investigators participating in the study will implement the protocol. During the study, the study site will assign a special person to review the completeness and correctness of the data submitted by each participating site.

02

Conditions studied

  • Echocardiography

Keywords

  • Neonatal Echocardiogram
  • Reference Ranges
  • Preterm Infants
03

In context

Lead sponsor

Children's Hospital of Chongqing Medical University is the lead sponsor of 35 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 28 Days
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

healthy neonates and preterm Infants

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Outpatient or inpatient neonate
  • Gestational age > 30weeks and birthweight > 1250 grams
  • Appropriate for gestational age
  • Without perinatal asphyxia
  • Without skin lesion on the left chest wall
  • with family for neonatal echocardiography

Exclusion criteria

Exclusion Criteria:

  • specialist cardiac ultrasound suggests congenital heart disease;
  • PDA with hemodynamic abnormalities, defined as: PDA > 1.5 mm (left-to-right shunt) and left atrial diameter/aortic root > 1.5 or the need for the use of inotropes;
  • invasive mechanical ventilation therapy,
  • non-invasive mechanical ventilation with FiO2 >0.3
  • major anomalies
  • blood culture-proven neonatal sepsis
  • persistent pulmonary hypertension
  • renal failure
  • necrotizing enterocolitis ≥ stage II
  • post surgery
  • Maternal history of severe anemia, or prenatal massive bleeding
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,500 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Changes in left atrial anteroposterior diameter with increasing age

    The Left atrial systolic anteroposterior diameter was measured by M-mode ultrasound through the aortic root in the long axis of the parasternal left ventricle

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

  2. Changes in interventricular septum thickness with increasing age

    The Interventricular septal thickness was measured by left ventricular M-mode ultrasound in the long axis of the parasternal left ventricle

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

  3. Changes in left ventricular posterior wall thickness at end diastole with increasing age

    The left ventricular posterior wall thickness at end diastole was measured by left ventricular M-mode ultrasound in the long axis of the parasternal left ventricle

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

  4. Changes in left ventricular end diastolic diameter with increasing age

    The left ventricular end diastolic diameter was measured by left ventricular M-mode ultrasound in the long axis of the parasternal left ventricle

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

  5. Changes in left ventricular end systolic diameter with increasing age

    The left ventricular end systolic diameter was measured by left ventricular M-mode ultrasound in the long axis of the parasternal left ventricle

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

  6. Changes in right ventricular anteroposterior diameter at end diastole with increasing age

    The right ventricular anteroposterior diameter at end diastole was measured by left ventricular M-mode ultrasound in the long axis of the parasternal left ventricle

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

  7. Changes in right ventricular outflow tract diameter with increasing age

    The right ventricular outflow tract diameter was measured in the short-axis pulmonary valve orifice view of the parasternal great arteries

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

  8. Changes in left ventricular ejection fraction with increasing age

    Left ventricular ejection fraction can be calculated by measuring left ventricular end-diastolic diameter and left ventricular end-systolic diameter in a standard parasternal left ventricular long-axis view, at the level of mitral chordae tendineae, or parasternal left ventricular short-axis view, at the level of papillary muscles, with the sampling line perpendicular to the interventricular septum and left ventricular posterior wall

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

Secondary outcomes

  1. Changes in left ventricular outflow tract diameter with increasing age

    In the standard parasternal long-axis view, images were frozen when the aortic valve was completely opened during systole, and the distance between the anterior and posterior aortic walls at the level of aortic root attachment was measured with an electronic cursor to obtain the left ventricular outflow tract diameter

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

  2. Changes in main pulmonary artery diameter with increasing age

    In the parasternal cardiac base short-axis view, the left and right pulmonary arteries were exposed at the same time, and the diameter of the main pulmonary artery was measured

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

  3. Changes in Inferior vena cava diameter with increasing age

    Inferior vena cava diameter was measured by M-mode ultrasound in the subxiphoid long-axis plane by transthoracic ultrasound

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

  4. Changes in Simpson 's method for measuring ejection fraction with increasing age

    Through the apical four-chamber view or apical two-chamber view, for the tracing of diastolic and systolic endocardium, divide the heart into several (generally 20) cylinders, calculate the volume and add them to obtain the left ventricular end-diastolic and end-systolic volumes, and then calculate the ejection fraction

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

Other outcomes

  1. Changes in Aortic Velocity Time Integral(VTI)with increasing age

    In the apical five-chamber view, select the color Doppler mode to display the aortic blood flow signal and direction, place the sampling volume below the arterial orifice, adjust the blood flow direction as parallel as possible to the sampling line through the left and right swing probe, and select the pulsed Doppler mode (PW), then the velocity time integral (VTI) image of aortic blood flow can be obtained. Trace the aortic velocity-time integral image and calculate the VTI value in cm by computer or plotter. Select 3-5 consecutive VTI images within the same respiratory cycle for measurement and average to reduce the impact of the respiratory cycle

    Time frame: 5 time points (1 day, 3 days, 7 days, 14 days and 28 days after birth)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • El-Khuffash A, Herbozo C, Jain A, Lapointe A, McNamara PJ. Targeted neonatal echocardiography (TnECHO) service in a Canadian neonatal intensive care unit: a 4-year experience. J Perinatol. 2013 Sep;33(9):687-90. doi: 10.1038/jp.2013.42. Epub 2013 Apr 25. PubMed 23619373 ↗
  • Shiraishi H, Yanagisawa M. Pulsed Doppler echocardiographic evaluation of neonatal circulatory changes. Br Heart J. 1987 Feb;57(2):161-7. doi: 10.1136/hrt.57.2.161. PubMed 3814451 ↗
  • Kluckow M, Evans N. Superior vena cava flow in newborn infants: a novel marker of systemic blood flow. Arch Dis Child Fetal Neonatal Ed. 2000 May;82(3):F182-7. doi: 10.1136/fn.82.3.f182. PubMed 10794783 ↗
  • Schmitz L, Stiller B, Pees C, Koch H, Xanthopoulos A, Lange P. Doppler-derived parameters of diastolic left ventricular function in preterm infants with a birth weight <1500 g: reference values and differences to term infants. Early Hum Dev. 2004 Feb;76(2):101-14. doi: 10.1016/j.earlhumdev.2003.11.003. PubMed 14757262 ↗
  • Cosyns B, Lancellotti P. Normal reference values for echocardiography: a call for comparison between ethnicities. Eur Heart J Cardiovasc Imaging. 2016 May;17(5):523-4. doi: 10.1093/ehjci/jev353. Epub 2016 Mar 13. No abstract available. PubMed 26976356 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05462301
Lead sponsor
Children's Hospital of Chongqing Medical University
Collaborators
Shanxi Provincial Maternity and Children's Hospital, Inner Mongolia Maternal and Child Health Care Hospital, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Ningxia Medical University
Responsible party
Wang Jianhui (Project Leader, Children's Hospital of Chongqing Medical University) — Principal investigator
First posted
Jul 18, 2022
Start date
Nov 15, 2022
Primary completion
Dec 30, 2024 (estimated)
Completion
Dec 30, 2024 (estimated)
Last update
Jul 16, 2024

Study contacts

Wang Jianhui, Doctor
Contact
tonywenhui@hotmail.com
+8613678428167
Dong Wenhui, Master
Contact
376561086@qq.com
+8615826122681
Wang Jianhui, Doctor
study director · Children's Hospital of Chongqing Medical University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion